STERIS plc (STE)

NYSE: STE · Real-Time Price · USD
247.07
+3.31 (1.36%)
At close: Aug 13, 2025, 4:00 PM
247.07
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:12 PM EDT
1.36%
Market Cap 24.33B
Revenue (ttm) 5.57B
Net Income (ttm) 646.64M
Shares Out 98.49M
EPS (ttm) 6.53
PE Ratio 37.84
Forward PE 23.97
Dividend $2.28 (0.92%)
Ex-Dividend Date Sep 4, 2025
Volume 455,064
Open 243.86
Previous Close 243.76
Day's Range 242.90 - 248.06
52-Week Range 200.98 - 252.79
Beta 0.92
Analysts Buy
Price Target 268.25 (+8.57%)
Earnings Date Aug 6, 2025

About STE

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jun 1, 1992
Employees 17,787
Stock Exchange NYSE
Ticker Symbol STE
Full Company Profile

Financial Performance

In 2024, STERIS's revenue was $5.46 billion, an increase of 6.24% compared to the previous year's $5.14 billion. Earnings were $614.64 million, an increase of 62.50%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for STE stock is "Buy." The 12-month stock price target is $268.25, which is an increase of 8.57% from the latest price.

Price Target
$268.25
(8.57% upside)
Analyst Consensus: Buy
Stock Forecasts

News

STERIS plc (STE) Q1 2026 Earnings Call Transcript

STERIS plc (NYSE:STE) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Daniel A. Carestio - President, CEO & Director Julie Winter - Vice President of Investor Relation...

6 days ago - Seeking Alpha

STERIS Announces Chief Financial Officer Transition

Long-time CFO Michael J. Tokich to be succeeded by Karen L.

7 days ago - GlobeNewsWire

STERIS Announces Financial Results for Fiscal 2026 First Quarter

DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 first quarter ended June 30, 2025. Total rev...

7 days ago - GlobeNewsWire

STERIS Raises Dividend to $0.63 per share

DUBLIN, IRELAND, July 30, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.63 per share. ...

14 days ago - GlobeNewsWire

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 first quarter resul...

22 days ago - GlobeNewsWire

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report by Product (Gynecological Chairs, Gynecological Tables), Application (Uro...

3 months ago - GlobeNewsWire

Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S.

Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major tai...

3 months ago - Seeking Alpha

STERIS plc (STE) Q4 2025 Earnings Call Transcript

STERIS plc (NYSE:STE) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Da...

3 months ago - Seeking Alpha

Why This Medical Equipment Stock Is Today's S&P 500 Winner

Steris beat quarter.y earnings and revenue expectations and got a price target boost from Morgan Stanley.

3 months ago - Barrons

Steris forecasts annual profit above estimates on strong medical equipment sales

Medical equipment maker Steris forecast annual profit above analysts' estimate on Wednesday, banking on strength in its biggest segment that sells sterilization products, sending its shares up more th...

3 months ago - Reuters

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

Medical equipment maker Steris (STE) on Wednesday afternoon reported fiscal fourth-quarter 2025 financial results. A summary of its key numbers is below.

3 months ago - Investopedia

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 14, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 fourth quarter and full year ended March 31, ...

3 months ago - GlobeNewsWire

STERIS Declares Dividend of $0.57 per share

DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. T...

3 months ago - GlobeNewsWire

10 Undervalued Dividend Growth Stocks: May 2025

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth...

3 months ago - Seeking Alpha

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and...

4 months ago - GlobeNewsWire

Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'

Upgraded Steris to 'strong buy' with a fair value of $254 per share due to strong recovery in its Applied Sterilization Technologies (AST) business. AST segment showed 9.5% organic growth, with manage...

5 months ago - Seeking Alpha

STERIS plc (STE) Q3 2025 Earnings Call Transcript

STERIS plc (NYSE:STE) Q3 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Julie Winter – Investor Relations Mike Tokich – Senior Vice President and Chief Financial Offic...

6 months ago - Seeking Alpha

Steris lowers annual profit forecast due to a stronger dollar

Medical equipment maker Steris lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.

6 months ago - Reuters

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total...

6 months ago - GlobeNewsWire

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter fina...

7 months ago - GlobeNewsWire

STERIS Announces Outcome of Ethylene Oxide Trial

DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix O...

7 months ago - GlobeNewsWire

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted EP...

9 months ago - Seeking Alpha

STERIS plc (STE) Q2 2025 Earnings Call Transcript

STERIS plc (STE) Q2 2025 Earnings Call Transcript

9 months ago - Seeking Alpha

Steris beats quarterly estimates on continued demand for medical procedures

Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools.

9 months ago - Reuters

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. ...

9 months ago - GlobeNewsWire